Stelo by Dexcom is the first over-the-counter continuous glucose monitor (CGM) in the U.S. Though specifically designed for people with prediabetes or type 2 diabetes who don’t use insulin, anyone 18 ...
StockStory.org on MSN
Unpacking Q4 earnings: ResMed (NYSE:RMD) in the context of other patient monitoring stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
StockStory.org on MSN
Q4 patient monitoring earnings review: First prize goes to iRhythm (NASDAQ:IRTC)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results